Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Operating Margin (2020 - 2025)

Historic Operating Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 91.78%.

  • SOPHiA GENETICS's Operating Margin rose 51300.0% to 91.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 95.28%, marking a year-over-year increase of 102800.0%. This contributed to the annual value of 102.14% for FY2024, which is 178300.0% up from last year.
  • Latest data reveals that SOPHiA GENETICS reported Operating Margin of 91.78% as of Q3 2025, which was up 51300.0% from 100.92% recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Operating Margin ranged from a high of 90.2% in Q1 2025 and a low of 230.37% during Q1 2022
  • For the 5-year period, SOPHiA GENETICS's Operating Margin averaged around 138.49%, with its median value being 118.87% (2024).
  • As far as peak fluctuations go, SOPHiA GENETICS's Operating Margin crashed by -738000bps in 2022, and later soared by 1014700bps in 2023.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Operating Margin stood at 192.09% in 2021, then soared by 41bps to 112.69% in 2022, then increased by 1bps to 111.13% in 2023, then rose by 11bps to 98.37% in 2024, then grew by 7bps to 91.78% in 2025.
  • Its Operating Margin stands at 91.78% for Q3 2025, versus 100.92% for Q2 2025 and 90.2% for Q1 2025.